Cargando…

Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma

BACKGROUND: Real‐world evidence is sparse on the benefits of allergen immunotherapy [AIT; subcutaneous/sublingual immunotherapy (SCIT/SLIT)], the only disease‐modifying intervention for allergic rhinitis (AR) with long‐term efficacy. This real‐life study evaluated the effect of six AITs (native poll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wahn, Ulrich, Bachert, Claus, Heinrich, Joachim, Richter, Hartmut, Zielen, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585786/ https://www.ncbi.nlm.nih.gov/pubmed/30183091 http://dx.doi.org/10.1111/all.13598

Ejemplares similares

Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study
por: Blome, Christine, et al.
Publicado: (2020)

Sublingual immunotherapy provides long‐term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real‐world database analysis
por: Zielen, S., et al.
Publicado: (2017)

Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen
por: Ahlbeck, Lars, et al.
Publicado: (2022)

Seasonal distribution of inhaled allergens in allergic asthma patients with or without allergic rhinitis
por: Tian, Ruxian, et al.
Publicado: (2022)

Birch-induced allergic rhinitis: Results of exposure during nasal allergen challenge, environmental chamber, and pollen season
por: Gherasim, Alina, et al.
Publicado: (2023)

Systemic and local eosinophil inflammation during the birch pollen season in allergic patients with predominant rhinitis or asthma
por: Kämpe, Mary, et al.
Publicado: (2007)

Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
por: Vogelberg, Christian, et al.
Publicado: (2020)

Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial
por: Klimek, Ludger, et al.
Publicado: (2015)

The Major Birch Pollen Allergen Bet v 1 Induces Different Responses in Dendritic Cells of Birch Pollen Allergic and Healthy Individuals
por: Smole, Ursula, et al.
Publicado: (2015)

Prophylactic and Therapeutic Effects of Oral Immunotherapy on Birch Pollen-Induced Allergic Conjunctivitis in Mice with a Rice-Based Edible Vaccine Expressing a Hypoallergenic Birch Pollen Allergen
por: Ishida, Waka, et al.
Publicado: (2021)

Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
por: Drazdauskaitė, Gabija, et al.
Publicado: (2020)

Nasal IgE in subjects with allergic and non-allergic rhinitis
por: Eckrich, Jonas, et al.
Publicado: (2020)

Analysis of Peanut Allergen Components Sensitization and Cross Reaction with Pollen Allergen in Chinese Southerners with Allergic Rhinitis and/or Asthma
por: Luo, Wenting, et al.
Publicado: (2021)

Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis
por: Novak, Natalija, et al.
Publicado: (2022)

Allergen immunotherapy and allergic rhinitis: false beliefs
por: Calderón, Moisés A, et al.
Publicado: (2013)

Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis
por: McDonell, Amanda L., et al.
Publicado: (2015)

ARIA Care Pathways 2019: Next-Generation Allergic Rhinitis Care and Allergen Immunotherapy in Malaysia
por: Abdul Latiff, Amir Hamzah, et al.
Publicado: (2023)

Evaluation of safety and tolerability of a rush up-dosing allergen-specific immunotherapy with grass pollen, birch, hazel, and alder allergoid in children with allergic rhinoconjunctivitis, with or without asthma
por: Traina, Giovanni Maria, et al.
Publicado: (2021)

Long-term benefit after allergen immunotherapy to HDM in elderly patients with allergic rhinitis
por: Bożek, Andrzej, et al.
Publicado: (2023)

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014)

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis
por: Sohn, Myung Hyun
Publicado: (2018)

Intradermal Allergen Immunotherapy for Allergic Rhinitis: Current Evidence
por: Atipas, Kawita, et al.
Publicado: (2022)

Brazilian guidelines for allergen immunotherapy in the treatment of allergic rhinitis
por: Aarestrup, Fernando Monteiro, et al.
Publicado: (2023)

The Effect of Seasonal Priming on Specific Inhalation Challenges With Birch and Grass Allergen Among Persons With Allergic Rhinitis
por: Ørby, Pia V., et al.
Publicado: (2021)

Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens
por: Fujii, Tatsuya, et al.
Publicado: (2022)

Pimecrolimus Is a Potent Inhibitor of Allergic Reactions to Hymenopteran Venom Extracts and Birch Pollen Allergen In Vitro
por: Heneberg, Petr, et al.
Publicado: (2015)

First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients
por: Bergmann, Karl-Christian, et al.
Publicado: (2020)

Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen
por: Ueda, Shoko, et al.
Publicado: (2022)

Allergen immunotherapy for allergic asthma: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2016)

Allergic asthma: An indication for allergen immunotherapy
por: Ankermann, Tobias, et al.
Publicado: (2023)

Prevalence of allergic rhinitis and asthma in Poland in relation to pollen counts
por: Lipiec, Agnieszka, et al.
Publicado: (2019)

Chinese Birch Pollen Allergy and Immunotherapy in Mice
por: Xie, Zhijuan, et al.
Publicado: (2019)

167 Allergen Sensitization in Children with Allergic Rhinitis and Asthma in Guatemala
por: Rigalt, Ann Michelle, et al.
Publicado: (2012)

Mechanisms of allergen-specific immunotherapy for allergic rhinitis and food allergies
por: Lam, Hiu Yan, et al.
Publicado: (2020)

Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update
por: Wang, Chengshuo, et al.
Publicado: (2022)

Allergen‐specific immunotherapy with apples: selected cultivars could be a promising tool for birch pollen allergy
por: Nothegger, B., et al.
Publicado: (2020)

Management of patients with seasonal allergic rhinitis: Diagnostic consideration of sensitization to non‐frequent pollen allergens
por: Höflich, Conny, et al.
Publicado: (2021)

Pollen aero allergens and the climate in mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care
por: De Jong, Hilda J.I., et al.
Publicado: (2020)

Cytokine Profile of Patients with Allergic Rhinitis Caused by Pollen, Mite, and Microbial Allergen Sensitization
por: Tyurin, Yury A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ndg71l0cg8qms90hv9nipgh8td